Thus our data imply that these dendritic polymers might be considered as a novel class of modulators of EGFR phosphorylation that can be selected to either stimulate or inhibit EGFR signaling- an important cellular signal transduction pathway in diseases such as cancer and diabetes-induced cardiovascular and renal diseases. This evidence concerns the gene EGFR and kidney disorder.